A reader who must remain anonymous took issue with parts of today’s item dealing with California stem cell royalties. The reader said via email:
“Not to complain, but I was disappointed to see the directing of royalties from CIRM inventions away from the General Fund to a special set aside fund.”
The reader then critiqued the following sentence in the it…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.